News Website

Pfizer targets VEGF bispecific white space | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Pfizer targets VEGF bispecific white space | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Published: May 21, 2026, 12:46 p.m.

Read Full Article

BBC Surrey. . A content creator from Surrey, who has both adenomyosis and endometriosis, said her periods were so bad they felt 'like a chainsaw inside of me'. More here: https://bbc.in/4uQAOh6 - Facebook

BBC Surrey. . A content creator from Surrey, who has both adenomyosis and endometriosis, said her periods were so bad they felt 'like a chainsaw inside of me'. More here: …

Published: May 20, 2026, 7:40 a.m.

Read Full Article

BBC Surrey. . A content creator from Surrey, who has both adenomyosis and endometriosis, said her periods were so bad they felt 'like a chainsaw inside of me'. More here: https://bbc.in/4uQAOh6 - facebook.com

BBC Surrey. . A content creator from Surrey, who has both adenomyosis and endometriosis, said her periods were so bad they felt 'like a chainsaw inside of me'. More here: …

Published: May 20, 2026, 7:40 a.m.

Read Full Article

Women face $1200 bill as key endo drug axed from PBS - The Mercury

Women face $1200 bill as key endo drug axed from PBS The Mercury

Published: May 19, 2026, 8:03 p.m.

Read Full Article

Women face $1200 bill as key endo drug axed from PBS - The Cairns Post

Women face $1200 bill as key endo drug axed from PBS The Cairns Post

Published: May 19, 2026, 7:47 p.m.

Read Full Article

Merck’s billion-dollar Kelun bet pays off as TROP2 improves survival in endometrial cancer - BioSpace

Merck’s billion-dollar Kelun bet pays off as TROP2 improves survival in endometrial cancer BioSpace

Published: May 19, 2026, 11:19 a.m.

Read Full Article

Cyclana Bio Granted Health Research Authority Approval and Recruits First Patients for Clinical Observational Study in Endometriosis - BioSpace

Cyclana Bio Granted Health Research Authority Approval and Recruits First Patients for Clinical Observational Study in Endometriosis BioSpace

Published: May 19, 2026, 11:15 a.m.

Read Full Article

Acer Aspire Vero 16: $320 off at Best Buy - Mashable

Acer Aspire Vero 16: $320 off at Best Buy Mashable

Published: May 19, 2026, 9 a.m.

Read Full Article

Women face $1200 bill as key endo drug axed from PBS - Gold Coast Bulletin

Women face $1200 bill as key endo drug axed from PBS Gold Coast Bulletin

Published: May 19, 2026, 7:50 a.m.

Read Full Article

Merck-Kelun ADC boosts survival in phase 3 endometrial cancer, stokes TROP2 race - CHOSUNBIZ - Chosunbiz

Merck-Kelun ADC boosts survival in phase 3 endometrial cancer, stokes TROP2 race - CHOSUNBIZ Chosunbiz

Published: May 19, 2026, 6:54 a.m.

Read Full Article

Latest Articles

Pfizer targets VEGF bispecific white space | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

BBC Surrey. . A content creator from Surrey, who has both adenomyosis and endometriosis, said her periods were so bad they felt 'like a chainsaw inside of me'. More here: https://bbc.in/4uQAOh6 - Facebook

BBC Surrey. . A content creator from Surrey, who has both adenomyosis and endometriosis, said her periods were so bad they felt 'like a chainsaw inside of me'. More here: https://bbc.in/4uQAOh6 - facebook.com

Women face $1200 bill as key endo drug axed from PBS - The Mercury

Women face $1200 bill as key endo drug axed from PBS - The Cairns Post

Merck’s billion-dollar Kelun bet pays off as TROP2 improves survival in endometrial cancer - BioSpace

Cyclana Bio Granted Health Research Authority Approval and Recruits First Patients for Clinical Observational Study in Endometriosis - BioSpace

Acer Aspire Vero 16: $320 off at Best Buy - Mashable

Women face $1200 bill as key endo drug axed from PBS - Gold Coast Bulletin

Merck-Kelun ADC boosts survival in phase 3 endometrial cancer, stokes TROP2 race - CHOSUNBIZ - Chosunbiz

Subscribe to Our Newsletter